Medication info
Codyvad Tablet 80/12.5 mg

Codyvad Tablet 80/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Hyundai Pharmaceutical Co., Ltd.
Appearance
Bright orange oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200807020 · Notified 2008.06.25 · Insurance code 642001680

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults
Adult dose
○ Adults The recommended dose is 1 tablet containing valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken regardless of meals, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg applies when valsartan 160 mg/hydrochlorothiazide 12.5 mg has been prescribed to lower blood pressure. The maximum antihypertensive effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance of 30 mL/min or higher). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not exceed 80 mg of valsartan daily.

Ingredients

Manufacturer
Hyundai Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy. In other words, it is utilized as an additional treatment to stabilize blood pressure in cases where basic antihypertensive agents are ineffective.

How to take

Adult dose

○ Adults The recommended dose is 1 tablet containing valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken regardless of meals, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg applies when valsartan 160 mg/hydrochlorothiazide 12.5 mg has been prescribed to lower blood pressure. The maximum antihypertensive effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance of 30 mL/min or higher). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not exceed 80 mg of valsartan daily.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to this medication or its components, or who have specific liver or kidney disorders, should not take this medication. Patients with electrolyte imbalance, weakened kidney or liver function, the elderly, and those with heart diseases should exercise extra caution when using this medication. This medication has the effect of lowering blood pressure, so dizziness or hypotension may occur shortly after starting treatment, requiring careful monitoring. As it can affect potassium levels, potassium supplements or potassium-containing drugs should not be taken without consulting a physician. During the course of treatment, regular checks on electrolytes and kidney function should be carried out to ensure no abnormalities arise. The hydrochlorothiazide component can be sensitive to sunlight, which may increase the risk of skin cancer, so it is advisable to minimize sun exposure and regularly check skin condition. This medication may interact with other drugs, so any current medications must be disclosed to healthcare professionals. Dizziness or drowsiness may occur while driving or operating machinery, so caution is advised. It is safest for women who are pregnant, planning to become pregnant, or breastfeeding not to use this medication. In case of overdose, symptoms such as hypotension, arrhythmias, and electrolyte disturbances may occur, so the prescribed dosage must be strictly adhered to. The safety and efficacy of this medication have not been established in children, so its use is not recommended. Store in a place out of reach of children, avoiding moisture, and keep well sealed in its original container.

Side effects

headache, dizziness, nasopharyngitis, fatigue, low back pain, cough, upper respiratory tract infection, diarrhea, joint pain, abdominal pain, upper abdominal pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, indigestion, dyspnea, erectile dysfunction, enteritis, hyperhidrosis, sensory loss, insomnia, hypokalemia, hypotension, influenza, muscle spasm, muscle strain, nausea, nasal congestion, nasal bleeding, throat pain, otitis media, limb pain, paresthesia, pharyngodynia, fever, sinus congestion, sinusitis, drowsiness, leg cramps, polyuria, palpitations, rash, ligament sprain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, weakness, angioedema, itching, serum sickness, vasculitis, alopecia, renal impairment, myalgia, anaphylaxis-like symptoms, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, exacerbation of systemic lupus erythematosus, hypoglycemia, rhabdomyolysis, elevated AST, palpitations, edema, weakness, hypertriglyceridemia, increased creatine kinase, decreased hemoglobin, increased serum potassium, dizziness, vasculitis, elevated liver function tests, bullous dermatitis, joint pain, low back pain, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, acute respiratory distress syndrome, pneumonia, acute angle closure glaucoma, choroidal effusion, urticaria, photosensitivity reaction, erythematosus lupus, decreased appetite, vomiting, constipation, gastrointestinal discomfort, intrahepatic cholestasis, jaundice, orthostatic hypotension, cardiac arrhythmia, sensory loss, sedation, sleep disorders, depression, paresthesia, visual impairment, thrombocytopenia, leukopenia, bone marrow dysfunction, hemolytic anemia, erectile dysfunction, hypersensitivity reaction, pulmonary edema, decreased serum sodium, hypomagnesemia, hypochloremic alkalosis, increased serum cholesterol, increased triglycerides, hyperglycemia, diabetes mellitus, increased serum uric acid, increased serum creatinine, increased uric acid in blood, hypotension, tachycardia, nausea, drowsiness, hypovolemia, arrhythmia, muscle stiffness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It should also be kept in a cool place below 30 degrees Celsius for optimal efficacy.

Appearance and packaging

Appearance

Bright orange oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.